Literature DB >> 35103495

Early Post-Hospitalization Hemoglobin Recovery and Clinical Outcomes in Survivors of Critical Illness: A Population-Based Cohort Study.

Matthew A Warner1, Andrew C Hanson1, Phillip J Schulte1, Nareg H Roubinian2,3,4, Curt Storlie1, Gabriel Demuth1, Ognjen Gajic1, Daryl J Kor1.   

Abstract

Anemia is common during critical illness, is associated with adverse clinical outcomes, and often persists after hospitalization. The goal of this investigation is to assess the relationships between post-hospitalization hemoglobin recovery and clinical outcomes after survival of critical illness. This is a population-based observational study of adults (≥18 years) surviving hospitalization for critical illness between January 1, 2010 and December 31, 2016 in Olmsted County, Minnesota, United States with hemoglobin concentrations and clinical outcomes assessed through one-year post-hospitalization. Multi-state proportional hazards models were utilized to assess the relationships between 1-month post-hospitalization hemoglobin recovery and hospital readmission or death through one-year after discharge. Among 6460 patients that survived hospitalization for critical illness during the study period, 2736 (42%) were alive, not hospitalized, and had available hemoglobin concentrations assessed at 1-month post-index hospitalization. Median (interquartile range) age was 69 (56, 80) years with 54% of male gender. Overall, 86% of patients had anemia at the time of hospital discharge, with median discharge hemoglobin concentrations of 10.2 (9.1, 11.6) g/dL. In adjusted analyses, each 1 g/dL increase in 1-month hemoglobin recovery was associated with decreased instantaneous hazard for hospital readmission (HR 0.87 [95% CI 0.84-0.90]; p < 0.001) and lower mortality (HR 0.82 [95% CI 0.75-0.89]; p < 0.001) through one-year post-hospitalization. The results were consistent in multiple pre-defined sensitivity analyses. Impaired early post-hospitalization hemoglobin recovery is associated with inferior clinical outcomes in the first year of survival after critical illness. Additional investigations are warranted to evaluate these relationships.

Entities:  

Keywords:  anemia; critical illness; hemoglobin; intensive care; readmission; transfusion

Mesh:

Substances:

Year:  2022        PMID: 35103495      PMCID: PMC9339589          DOI: 10.1177/08850666211069098

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   2.889


  28 in total

1.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Ann Intern Med       Date:  2007-10-16       Impact factor: 25.391

2.  From Tolerating Anemia to Treating Anemia.

Authors:  Aryeh Shander; Lawrence Tim Goodnough
Journal:  Ann Intern Med       Date:  2018-12-18       Impact factor: 25.391

3.  Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial.

Authors:  H L Corwin; A Gettinger; R M Rodriguez; R G Pearl; K D Gubler; C Enny; T Colton; M J Corwin
Journal:  Crit Care Med       Date:  1999-11       Impact factor: 7.598

4.  Transfusion practice in the intensive care unit: a 10-year analysis.

Authors:  Giora Netzer; Xinggang Liu; Anthony D Harris; Bennett B Edelman; John R Hess; Carl Shanholtz; David J Murphy; Michael L Terrin
Journal:  Transfusion       Date:  2010-10       Impact factor: 3.157

Review 5.  Anemia and Red Blood Cell Transfusion: Advances in Critical Care.

Authors:  Lena M Napolitano
Journal:  Crit Care Clin       Date:  2017-04       Impact factor: 3.598

6.  Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness.

Authors:  Edward Litton; Stuart Baker; Wendy N Erber; Shannon Farmer; Janet Ferrier; Craig French; Joel Gummer; David Hawkins; Alisa Higgins; Axel Hofmann; Bart De Keulenaer; Julie McMorrow; John K Olynyk; Toby Richards; Simon Towler; Robert Trengove; Steve Webb
Journal:  Intensive Care Med       Date:  2016-09-30       Impact factor: 17.440

Review 7.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.

Authors:  Walter A Rocca; Barbara P Yawn; Jennifer L St Sauver; Brandon R Grossardt; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2012-11-28       Impact factor: 7.616

8.  PREVENTT: preoperative intravenous iron to treat anaemia in major surgery: study protocol for a randomised controlled trial.

Authors:  Toby Richards; Ben Clevenger; Jane Keidan; Tim Collier; Andrew A Klein; Stefan D Anker; John D Kelly
Journal:  Trials       Date:  2015-06-04       Impact factor: 2.279

9.  Rochester Epidemiology Project Data Exploration Portal.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Lila J Finney Rutten; Veronique L Roger; Michelle Majerus; Daniel W Jensen; Scott M Brue; Cynthia M Bock-Goodner; Walter A Rocca
Journal:  Prev Chronic Dis       Date:  2018-04-12       Impact factor: 2.830

10.  Anemia in Critically Ill Patients With Acute Respiratory Distress Syndrome and Posthospitalization Physical Outcomes.

Authors:  Matthew A Warner; Daryl J Kor; Ryan D Frank; Victor D Dinglas; Pedro Mendez-Tellez; Cheryl R Dennison Himmelfarb; Carl B Shanholtz; Curtis B Storlie; Dale M Needham
Journal:  J Intensive Care Med       Date:  2020-03-24       Impact factor: 3.510

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.